Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: Growth hormone isoform profiles in Japanese male subjects

Drug Testing and Analysis

Volumn 2, Issue 11-12, 2010, Pages 548-556

  Okano, Masato ^a   Nishitani, Yasunori ^a   Sato, Mitsuhiko ^a   Ikekita, Ayako ^a   Kageyama, Shinji ^a  

^a LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Doping; GH isoform; GHRP 2; Growth hormone; Growth hormone secretagogue

Indexed keywords

IMMUNOLOGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

GROWTH HORMONE ISOFORM; GROWTH HORMONE RELEASING PEPTIDE-2; GROWTH HORMONE SECRETAGOGUES; GROWTH HORMONES; HUMAN GROWTH HORMONE; INTRAVENOUS ADMINISTRATION; ISOFORMS; PEPTIDE GROWTH;

PEPTIDES;

HUMAN GROWTH HORMONE; PRALMORELIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; DOPING; DRUG DETERMINATION; HUMAN; IMMUNOASSAY; JAPANESE; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TANDEM MASS SPECTROMETRY;

EID: 78650675002     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.166     Document Type: Article

References (22)

1. R. I. Holt, Drug Test. Anal. 2009, 1, 426.
2. WADA, The 2010 Prohibited List, Available at: [17 April 2010].
3. M. Bidlingmaier, Z. Wu, C. J. Strasburger, Bailliere's Best Pract. Res. Clin. Endocrinol. Metab. 2000, 14, 99.
4. Z. Wu, M. Bidlingmaier, R. Dall, C. J. Strasburger, Lancet 1999, 353, 895.
5. M. Bidlingmaier, Z. Wu, C. J. Strasburger, J. Pediatr. Endocrinol. Metab. 2001, 14, 1077.
6. S. Momomura, Y. Hashimoto, Y. Shimazaki, M. Irie, Endocr. J. 2000, 47, 97.
7. M. Bidlingmaier, J. Suhr, A. Ernst, Z. Wu, A. Keller, C. J. Strasburger, A. Bergmann, Clin. Chem. 2009, 55, 445.
8. O. Barroso, P. Schamasch, O. Rabin, Growth Horm. IGF Res. 2009, 19, 369.
9. UKAD statement. Available at: [15 May 2010].
10. J. K. Powrie, E. E. Bassett, T. Rosen, J. O. Jørgensen, R. Napoli, L. Sacca, J. S. Christiansen, B. A. Bengtsson, P. H. Sönksen, Growth Horm. IGF Res. 2007, 17, 220.
11. R. G. Smith, Endocr. Rev. 2005, 26, 346.
12. S. S. Pong, L. Y. Chaung, D. C. Dean, R. P. Nargund, A. A. Patchet, R. G. Smith, Mol. Endocrinol. 1996, 10, 57.
13. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Nature 1999, 402, 656.
14. M. Thevis, F. Wilkens, H. Geyer, W. Schänzer, Rapid Commun. Mass Spectrom. 2006, 20, 3393.
15. M. Okano, M. Sato, A. Ikekita, S. Kageyama, Rapid Commun. Mass Spectrom. 2010, 24, 2046.
16. M. Okano, A. Ikekita, M. Sato, S. Kageyama, in Recent Advances in Doping Analysis (16), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke). Sportverlag Strauß: Köln, 2008, p. 223.
17. A. Pinyot, Z. Nikolovski, J. Bosch, J. Segura, R. Gutiérrez-Gallego, Anal. Biochem. 2010, 399, 174.
18. J. Svensson, C. L. Boguszewski, F. Shibata, B. Carlsson, Growth Horm. IGF Res. 2003, 13, 1.
19. C. Y. Bowers, J. Pediatr. Endocrinol. 1993, 6, 21.
20. Kaken Pharmaceutical Co., Ltd. Drug Interview Form 2007, 877223.
21. A. Thomas, M. Kohler, J. Mester, H. Geyer, W. Schänzer, M. Petrou, M. Thevis, Drug Test. Anal. 2010, 2, 144.
22. L. Dehennin, Clin. Chem. 1994, 40, 106.